Stay updated on Dupilumab in Pediatric Asthma Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Pediatric Asthma Clinical Trial page.

Latest updates to the Dupilumab in Pediatric Asthma Clinical Trial page
- Check4 days agoChange DetectedThe site footer revision identifier changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check11 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the previous study record content with an error screen; the original detailed content and links have been removed and replaced by the error header and minimal footer.SummaryDifference20%

- Check38 days agoChange DetectedAdded a new publication citation for a post hoc analysis of the VOYAGE/EXCURSION pediatric asthma studies (J Allergy Clin Immunol, 2026) to the Publications section, providing additional context on dupilumab outcomes in children with asthma.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, indicating a minor deployment update to the page. The change does not alter the study content or how users interact with the page.SummaryDifference0.0%

- Check59 days agoChange DetectedAdded 2016 ( U.S. NIH Grant/Contract ) as a funding/identifier entry for the study, linking it to NIH support.SummaryDifference0.0%

Stay in the know with updates to Dupilumab in Pediatric Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Pediatric Asthma Clinical Trial page.